Barclays PLC Has $2.33 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Barclays PLC boosted its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 60.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,401 shares of the company's stock after acquiring an additional 20,125 shares during the period. Barclays PLC's holdings in Doximity were worth $2,327,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its position in shares of Doximity by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,144,748 shares of the company's stock worth $32,019,000 after acquiring an additional 17,430 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Doximity by 5.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,528 shares of the company's stock valued at $658,000 after purchasing an additional 1,303 shares during the last quarter. iA Global Asset Management Inc. raised its holdings in shares of Doximity by 36.5% during the second quarter. iA Global Asset Management Inc. now owns 44,683 shares of the company's stock worth $1,250,000 after purchasing an additional 11,946 shares during the period. Van ECK Associates Corp lifted its position in shares of Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock worth $72,000 after buying an additional 427 shares during the last quarter. Finally, nVerses Capital LLC bought a new position in shares of Doximity in the 2nd quarter worth about $215,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on DOCS shares. Robert W. Baird upped their target price on Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a report on Tuesday, September 17th. Canaccord Genuity Group restated a "hold" rating and set a $60.00 price objective (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Bank of America raised their target price on Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a research note on Monday, October 7th. Wells Fargo & Company upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $19.00 to $41.00 in a research report on Friday, November 8th. Finally, Baird R W upgraded shares of Doximity to a "strong-buy" rating in a research report on Tuesday, September 17th. Thirteen equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $52.59.

Doximity Stock Up 0.3 %

Doximity stock traded up $0.15 during midday trading on Thursday, hitting $58.42. The company's stock had a trading volume of 1,533,792 shares, compared to its average volume of 1,781,578. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The company has a market capitalization of $10.91 billion, a PE ratio of 67.15, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. The stock's 50-day moving average price is $50.31 and its 200-day moving average price is $39.60.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.